Safe Switch to an Oral Two‐Drug Regimen Based on Dolutegravir in People With Vertically Acquired HIV‐1: An Observational Multicenter Study

Safe Switch to an Oral Two‐Drug Regimen Based on Dolutegravir in People With Vertically Acquired HIV‐1: An Observational Multicenter Study

ABSTRACT Background and Aims People with vertically acquired HIV‐1 are exposed to antiretroviral drugs throughout their lives. Two‐drug regimens based on dolutegravir (DTG) are increasingly popular, showing excellent safety and efficacy and giving the opportunity to reduce toxicity and drug burden....

Full description

Saved in:
Bibliographic Details
Main Authors: Giulia Meraviglia, Anna Sala, Francesco Bassani, Laura Labate, Gabriele Pagani, Vania Giacomet, Antonio Di Biagio, Stefano Rusconi
Format: Article
Language:English
Published: Wiley 2025-07-01
Series:Health Science Reports
Subjects:
dolutegravir
drug resistance
treatment‐experienced
two‐drug regimen
vertical HIV
Online Access:https://doi.org/10.1002/hsr2.71047
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/hsr2.71047

Similar Items